News

Filter

Current filters:

RXi Pharmaceuticals

RXi Pharma and OPKO Health pooling RNAi assets

08-03-2013

US biotech firm RXi Pharmaceuticals (Nasdaq: RXII) and OPKO Health (NYSE: OPK) have entered into a strategic…

BiotechnologyFinancialLicensingOPKO HealthPharmaceuticalRXi Pharmaceuticals

RXi Pharma in-licenses targeted vaccine for gynecological cancers

22-09-2011

US biotech firm RXi Pharmaceuticals (Nasdaq: RXII) has licensed worldwide rights to develop and commercialize…

LicensingOncologyResearchRXi PharmaceuticalsVaccines

RXi Pharma to acquire Apthera in stock deal; Sanofi snares Genzyme

04-04-2011

Privately-held US biotech firm Apthera, which is developing a pipeline of peptide based immune-therapies,…

AptheraBiotechnologyGenzymeMergers & AcquisitionsNeuVaxOncologyPharmaceuticalRare diseasesRXi PharmaceuticalsSanofi-Aventis

RXi Pharmaceuticals plans new focus for its next generation RNAi technology

14-06-2010

US RNAi-based drug development firm RXi Pharmaceuticals has announced the company’s new focused…

DermatologicalsNeurologicalOncologyOphthalmicsPharmaceuticalResearchRXi Pharmaceuticals

COMPANY SPOTLIGHT

Menarini

Back to top